Reports for TEVA-OMEPRAZOLE
Brand name
TEVA-OMEPRAZOLE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02295407 |
Ingredients
OMEPRAZOLE |
Ingredient Strength
10 MG |
ATC Code
A02BC |
ATC Descriptor
DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-OMEPRAZOLE | 100 | Resolved | 2018-03-13 | 2018-05-30 | 42607 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2019-12-12 | 2020-08-28 | 101142 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2020-09-24 | 2020-12-17 | 125013 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2021-04-15 | 2022-01-28 | 137544 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2022-06-30 | 2023-04-28 | 163942 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2024-01-25 | 2024-03-14 | 217229 |
TEVA-OMEPRAZOLE | 100 | Resolved | 2024-01-25 | 2024-06-20 | 217231 |
Showing 1 to 7 of 7
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0